2674-0850

Frontiers in Drug Delivery

Frontiers Media SA

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 124 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact124 DOIs
2

Add abstracts to 16 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact16 DOIs
3

Deposit reference lists for 7 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact7 DOIs

DOIs for this ISSN

Showing the top 5 of 124 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 The Grand Challenges in Cardiovascular Drug Delivery (10.3389/fddev.2021.784731)
Abstract ORCID
63.94 18
2 Grand challenges in oral drug delivery (10.3389/fddev.2025.1571982)
Abstract ORCID
57.31 13
3 Suboptimal Inspiratory Flow Rates With Passive Dry Powder In… (10.3389/fddev.2022.855234)
Abstract ORCID
53.96 11
4 Receptor-mediated transcytosis for brain delivery of therape… (10.3389/fddev.2024.1360302)
ORCID
51.61 115
5 Lipid-based oral formulation in capsules to improve the deli… (10.3389/fddev.2023.1232012)
ORCID
48.86 89
6 Recent advances and future prospective of topical and transd… (10.3389/fddev.2022.957732)
ORCID
47.16 76
7 Regulatory Considerations Specific to Liposome Drug Developm… (10.3389/fddev.2022.901281)
ORCID
45.81 67
8 Receptor-mediated drug delivery of bispecific therapeutic an… (10.3389/fddev.2023.1227816)
ORCID
44.45 59
9 Topical ophthalmic administration: Can a drug instilled onto… (10.3389/fddev.2022.954771)
ORCID
42.47 49
10 Frontiers in hepatic drug delivery-grand challenges (10.3389/fddev.2023.1265446)
Abstract ORCID
38.91 5
11 Glioblastoma Vasculature: From its Critical Role in Tumor Su… (10.3389/fddev.2022.823412)
ORCID
36.93 29
12 Editorial: 3D printing in pharmaceuticals and medical applic… (10.3389/fddev.2024.1527225)
Abstract References ORCID
35.78 2
13 Formulation of Dry Powders for Inhalation Comprising High Do… (10.3389/fddev.2022.862336)
ORCID
34.04 22
14 Half a Century of Technological Advances in Pulmonary Drug D… (10.3389/fddev.2022.871147)
ORCID
34.04 22
15 Poor-tasting pediatric medicines: Part 1. A scoping review o… (10.3389/fddev.2025.1553286)
ORCID
34.04 22
16 Revolutionizing healthcare: the transformative potential of… (10.3389/fddev.2025.1556426)
ORCID
34.04 22
17 The Centenary of the Discovery of Insulin: An Update on the… (10.3389/fddev.2021.726675)
ORCID
33.56 21
18 Overcoming Blood-Brain Barrier Resistance: Implications for… (10.3389/fddev.2022.855017)
ORCID
33.06 20
19 The role of excipients in promoting topical and transdermal… (10.3389/fddev.2022.1049848)
ORCID
32.53 19
20 AAV2 and AAV9 tropism and transgene expression in the mouse… (10.3389/fddev.2023.1148795)
ORCID
31.97 18
21 Future theranostic strategies: emerging ovarian cancer bioma… (10.3389/fddev.2024.1339936)
ORCID
31.97 18
22 Endocytosis of insulin at the blood-brain barrier (10.3389/fddev.2022.1062366)
ORCID
31.38 17
23 Poly(2-methyl-2-oxazoline) as a polyethylene glycol alternat… (10.3389/fddev.2024.1383038)
ORCID
30.76 16
24 Grand Challenges in Vaccine Delivery: Lessons Learned From t… (10.3389/fddev.2022.964298)
Abstract ORCID
30.10 3
25 Multiscale physics-based in silico modelling of nanocarrier-… (10.3389/fddev.2024.1362660)
ORCID
29.40 14
26 Advanced drug delivery systems for oral squamous cell carcin… (10.3389/fddev.2025.1596964)
ORCID
29.40 14
27 Strategies for delivering drugs across the blood-brain barri… (10.3389/fddev.2025.1644633)
ORCID
29.40 14
28 Impact of simulated brain interstitial fluid flow on the che… (10.3389/fddev.2023.1227776)
ORCID
28.65 13
29 Transnasal-brain delivery of nanomedicines for neurodegenera… (10.3389/fddev.2023.1247162)
ORCID
28.65 13
30 Biodistribution of the saponin-based adjuvant Matrix-M™ foll… (10.3389/fddev.2023.1279710)
ORCID
28.65 13
31 Effects of Nicotine Exposure From Tobacco Products and Elect… (10.3389/fddev.2022.886099)
ORCID
27.85 12
32 On-Demand Drug Delivery: Recent Advances in Cardiovascular A… (10.3389/fddev.2022.913225)
ORCID
26.98 11
33 On a model-based approach to improve intranasal spray target… (10.3389/fddev.2023.1164671)
ORCID
26.98 11
34 A selective review of inhibitors of protein kinase C gamma:… (10.3389/fddev.2024.1364037)
ORCID
26.98 11
35 The Cell-Penetrating Peptide Tat Facilitates Effective Inter… (10.3389/fddev.2022.854703)
ORCID
26.03 10
36 Simple Autofluorescence-Restrictive Sorting of eGFP+ RPE Cel… (10.3389/fddev.2022.898568)
ORCID
25.00 9
37 Strategies to Improve the Targeting of Retinal Cells by Non-… (10.3389/fddev.2022.899260)
ORCID
25.00 9
38 Roles of biomaterials in modulating the innate immune respon… (10.3389/fddev.2023.1077253)
ORCID
25.00 9
39 Molecular distribution in intradermal injection for transfer… (10.3389/fddev.2023.1095181)
ORCID
25.00 9
40 Design of respirable sprayed microparticles of encapsulated… (10.3389/fddev.2023.1209534)
ORCID
25.00 9
41 Optimizing the design and dosing of dry powder inhaler formu… (10.3389/fddev.2022.973599)
ORCID
23.86 8
42 Targeting aerosol delivery to regions of nasal-associated ly… (10.3389/fddev.2024.1456538)
ORCID
23.86 8
43 In Vitro Estimation of Tracheobronchial and Alveolar Doses U… (10.3389/fddev.2022.901289)
ORCID
22.58 7
44 Inhalable Composite Microparticles Containing siRNA-Loaded L… (10.3389/fddev.2022.945459)
ORCID
22.58 7
45 Identification of transport systems involved in eflornithine… (10.3389/fddev.2023.1113493)
ORCID
22.58 7
46 Epithelium dynamics differ in time and space when exposed to… (10.3389/fddev.2023.1221628)
ORCID
22.58 7
47 Microneedle-enhanced drug delivery: fabrication, characteriz… (10.3389/fddev.2024.1425144)
ORCID
22.58 7
48 Strategies and delivery systems for cell-based therapy in au… (10.3389/fddev.2024.1436842)
ORCID
22.58 7
49 Editorial: Modelling of intravascular drug delivery using na… (10.3389/fddev.2025.1681622)
Abstract References ORCID
22.58 1
50 Role of microRNAs in the regulation of blood-brain barrier f… (10.3389/fddev.2022.1027098)
ORCID
21.13 6